Another priceless bit of leadership strategy here w/organizing ERP science for CNS disease trials processing. Considering the obvious confusion and lack of leadership @FDA and also considering the cost and importance of effective CNS disease treatment, WOW is right. This is a brilliant strategic move. BTW, AVXL has a partnership/type patent APP underway with the ERP leading manufacturer. Musashi would be proud, much more to follow on this IMO.